Mergers

InsuranceDekho merger to create new leader in segment, says RenewBuy

Reports have indicated that InsuranceDekho is in advanced talks to merge with RenewBuy in a cash-and-stock deal, which could value the combined entity at Rs 8,000 crore

Deal-making in India hits new high: M&A and PE lead the way, telecom tops

Mergers and acquisitions (M&A) contributed significantly to the surge, with a 57% increase in volume and 65% in value compared to the previous quarter.

CCI tightens oversight on digital mergers, mandates clearance for big deals

Digital mergers and acquisitions with at least 10 per cent of the global user base, gross merchandise value (GMV), or revenue in India now require approval from the Competition Commission of India

US oil, gas M&A activity rose 57% in 2023 as industry consolidated: Report

The jump in spending on dealmaking and expanding reserves marks a shift in strategy following a years-long focus on shareholder returns over growth, which many firms had employed

M&A deal value slows 9% to $38 billion in the first half of 2024

Deals to pick up in the second half, say bankers

PwC India expects rise in small, mid-size merger & acquisition transactions

PwC India anticipates an upswing in the India markets, especially in small to mid-size M&A (merger and acquisition) transactions and growth fundings driven by increasing investors' confidence. The year 2023 witnessed the emergence of a nuanced M&A landscape, with investors showing interests in diverse strategies and larger-scale ventures, even amid an overall decrease in PE investment, said Sanjeev Krishan, Chairperson, PwC in India. While PE deals were higher in volume, strategic deals dominated the top deals -- and domestic deals with group-level consolidations were a prominent theme. The first quarter of 2024 marked a resurgence in deal value and volume. According to a PwC report, top 10 deals of 2023 included JV buyouts, strategic investments, PE buyouts, and stock mergers, and contributed to 21 per cent of the total deal value. While PE deals were higher in volume overall, strategic deals dominated the top deals with domestic deals and group-level consolidations as a ...

Suven Pharma to acquire 67.5% stake in Sapala Organics for Rs 229.5 cr

Suven Pharmaceuticals on Thursday said it will acquire 67.5 per cent stake in Hyderabad-based Sapala Organics for Rs 229.5 crore. The company, which is one of the country's largest integrated contract development and manufacturing organisation players, has entered into a definitive agreement for investment in Sapala Organics, it said in a regulatory filing. Suven will acquire a 67.5 per cent stake for a consideration of Rs 229.5 crore, subject to customary working capital and net debt adjustments, it added. The company stated that it expects to complete the acquisition of the remaining equity stake in the target firm after FY2026-27, subject to the completion of customary closing conditions. Sapala has a presence in the fast-growing, Oligo and nucleic acid building blocks segment. "We see massive potential given it's a niche technology in the rapidly growing space. Nucleic acid based therapy targets diseases at a genetic level and has the potential to help patients immensely and c

Zee Entertainment faced Rs 432 crore merger costs in failed Sony deal

The merger agreement between Zee Entertainment and Culver Max Entertainment (Sony's India unit) was terminated on January 22 due to issues over leadership and unmet closing conditions

NCLT approves merger process for Reliance's arm Viacom18 and Star India

The merger will be done in two stages: the transfer of Viacom18's TV and streaming assets to Digital18 and the demerger and vesting of these assets from Digital18 to Star India

India leads Asia-Pacific region's M&A deals in Q1 2024: S&P Global

The number of deals closed in Q1 of 2023 is one more than the previous year

Value of mergers and acquisitions at lowest level in at least 76 months

With 98 deals, the total value of M&A stood at $1.8 billion. In the same month last year, the value was $8 billion across 204 deals

What makes engineering R&D space a target for mergers and acquisitions?

Infosys' acquisition of Germany-based in-tech is the 15th top deal so far

India's deal-making activity unfazed by elections: BNP Paribas' Murugaiyan

Murugaiyan, who oversaw close to a dozen ECM deals in 2023, says large sell-downs by private equity (PE) firms show the depth of the domestic market

M&A deal value in India declines 27% to $136 billion in 2023: Deloitte

M&A deal value in India fell 27 per cent in 2023 to USD 136 billion but the deals market is expected to remain steady in the current year, Deloitte India said in a report on Monday. "Amidst significant global challenges posed by high-interest rates, macroeconomic uncertainty, regulatory scrutiny, and geopolitical risks, India's M&A landscape stood resilient in 2023," 'India M&A Trends 2024' report said. "Despite global economic and geopolitical challenges, India's deals market is expected to remain steady, reflecting strong confidence from businesses and investors amidst a global economic slowdown," it added. In 2024, M&A (Merger and Acquisition) momentum is expected to remain steady with the manufacturing sector, driven by automotive, with deal growth expected in auto-components and Electric Vehicles (EVs). Also, the government's proactive initiatives to promote clean energy are expected to catalyse a significant rise in M&A within the energy sector. M&A in ..

Sun Pharma to acquire 16.33% stake in Surgimatix for $3.05 million

Sun Pharmaceutical Industries Ltd on Tuesday said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm for USD 3.05 million (over Rs 25 crore). Surgimatix is engaged in the business of developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries. It is yet to commence its commercial operations, Sun Pharmaceutical Industries said in a regulatory filing. The company has entered into an agreement with Surgimatix, Inc under which it has agreed to acquire 16.33 per cent shares of the latter, additionally, with the right to receive warrants equal to 20 per cent of shares purchased, it added. The cost of acquisition is USD 3.05 million, the filing said, adding that the acquisition is expected to be completed by February 2024, subject to fulfilment of certain conditions. Surgimatix was incorporated on November 19, 2007.

Working towards successful closure of merger with Sony: Zee Entertainment

Zee Entertainment Enterprises Ltd (ZEEL) on Friday said it is continuing to work towards a successful closure of its USD 10 billion merger with Culver Max Entertainment, formerly known as Sony Pictures Networks India, amid reports that the Japanese entity's board meeting to take a call on the fate of the protracted deal. In a regulatory filing, ZEEL said it was "not aware of, and cannot comment on" any board meeting held or proposed to be held by Culver Max Entertainment, given that these are internal matters of Sony. "We wish to reiterate that the Company is committed to the merger with Sony and is continuing to work towards a successful closure of the proposed merger and is engaging in good faith negotiations with Sony with a view to discuss the extension of the date required to make the Scheme effective, by a reasonable period of time," it said. The fate of the USD 10 billion merger between ZEEL and Culver Max Entertainment is hanging by a slim thread with the two parties yet to

Global corporate landscape 2023: Mergers, closures, and leadership shifts

From acquisitions & mergers to resignations 2023 has been a year of significant milestones in the global corporate world. Here is a recap on all the major event that unfolded in 2023

Sony-Zee merger may be finalised by November despite appeals from banks

IDBI Bank and Axis Finance have both filed pleas National Company Law Appellate Tribunal (NCLAT) challenging the merger

Hotels to steel: India Inc unlocks subsidiaries' value with mergers, splits

Combined value of deals reaches $32.9 bn in Q3 CY2023, the highest quarterly total since Q2 CY2022

ZEEL, NDTV: Will Zee Entertainment turn multi-bagger post NCLT clearance?

Zee Entertainment hits fresh 52-week high post approval by NCLT